An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder with familial and acquired forms. The familial form is associated with mutations in the perforin gene and both forms are associated with severe defects in lymphocyte cytotoxic function. We examined perforin-deficient mice as a model of HLH in order to gain insight into this poorly understood disorder. While these mice do not spontaneously develop HLH-like symptoms, we found that they manifest all of the features of HLH after infection with lymphocytic choriomeningitic virus (LCMV). Following LCMV infection, perforin-deficient mice develop fever, splenomegaly, pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and elevation of multiple serum cytokine levels, and hemophagocytosis is evident in many tissues. Investigation into how this phenotype develops has revealed that CD8+ T cells, but not natural killer (NK) cells, are necessary for the development of this disorder. Cytokine neutralization studies have revealed that interferon gamma (IFNγ) is uniquely essential as well. Finally, the excessive amount of IFNγ seen in affected mice appears to be driven by increased antigen presentation to CD8+ T cells. These studies provide insight into the pathophysiology of HLH, and provide new targets for specific therapeutic intervention in this fatal disorder.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data from mouse models of HLH and patients with cytokine storm indicate that the inability of CTLs to kill efficiently leads to prolonged activation of T cells, triggering a cascade of inflammatory tissue damage.
“Data from mouse models of HLH and patients with cytokine storm indicate that the inability of CTLs to kill efficiently leads to prolonged activation of T cells, triggering a cascade of inflammatory tissue damage.”
From Cytokine storm (2020) · cites this paper as [21]
Attempting to recapitulate HLH by continuous antigen exposure does not completely recreate the disease process, suggesting that persistent antigenemia is not sufficient.
“However, attempting to recapitulate HLH by continuous antigen exposure does not completely recreate the disease process, suggesting that persistent antigenemia is not sufficient (8).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [8]
The severity of MAS in this model is less than that seen in the perforin-deficient model.
“The severity of MAS in this model is less than that seen in the perforin-deficient model (8).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [8]
In murine models of primary HLH, IFN-γ plays a role and CD8+ T cells are required.
“Because of the role of IFN-γ and the requirement for CD8 + T cells in murine models of primary HLH (8), there has been much attention given to the antigen-specific receptors in cytokine storm.”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [8]
In primary familial HLH, antigen-driven CD8+ T cells are the major disease-inducing compartment.
“It is interesting to speculate whether the same process might also play some role in primary familial HLH, in which antigen-driven CD8 + T cells are clearly the major disease-inducing compartment (8).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [8]
Cites
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978 · see citing works
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902 · see citing works
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Dogniaux, S., Mathew, P. A., Henter, J., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,236 · see citing works
Lymphocyte-Mediated Cytotoxicity
Russell, J. H., & Ley, T. J. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100201.131730 · Cited by 1,122 · see citing works
Ahmed, R., Salmi, A. A., Butler, L. D., Chiller, J. M., & Oldstone, M. B. A. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.160.2.521 · Cited by 792 · see citing works
Henter, J., Elinder, G., & Öst, Å. (1991) · PubMed · Cited by 762 · see citing works
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
Buchmeier, M. J., Welsh, R. M., Dutko, F. J., & Oldstone, M. B. A. (1980) · Advances in immunology · doi:10.1016/s0065-2776(08)60197-2 · Cited by 545 · see citing works
Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
Henter, J., Elinder, G., Soder, O., Hansson, M., Andersson, B., & Andersson, U. (1991) · Blood · doi:10.1182/blood.v78.11.2918.2918 · Cited by 505 · see citing works
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes
Topham, D. J., Tripp, R. A., & Doherty, P. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5197 · Cited by 486 · see citing works
Crawford, F., Kozono, H., White, J., Marrack, P., & Kappler, J. W. (1998) · Immunity · doi:10.1016/s1074-7613(00)80572-5 · Cited by 459 · see citing works
Self-citationWysocka, M., Kubin, M. Z., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250307 · Cited by 452 · see citing works
INFECTION- AND MALIGNANCY-ASSOCIATED HEMOPHAGOCYTIC SYNDROMES
Janka, G., Imashuku, S., Elinder, G., Schneider, M., & Henter, J. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70521-9 · Cited by 451 · see citing works
Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis
Henter, J., Elinder, G., Söder, O., et al. (1991) · Acta Paediatrica · doi:10.1111/j.1651-2227.1991.tb11878.x · Cited by 450 · see citing works
How do cytotoxic lymphocytes kill their targets?
Shresta, S., Pham, C. T. N., Thomas, D. A., Graubert, T. A., & Ley, T. J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80227-6 · Cited by 390 · see citing works
Orange, J. S., & Biron, C. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1138 · Cited by 381 · see citing works
Tay, C. H., & Welsh, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.267-275.1997 · Cited by 322 · see citing works
Crowley, M. T., Inaba, K., Witmer-Pack, M. D., & Steinman, R. M. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90361-4 · Cited by 315 · see citing works
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Henter, J., Aricò, M., Elinder, G., Imashuku, S., & Janka, G. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70520-7 · Cited by 282 · see citing works
Spectrum of Perforin Gene Mutations in Familial Hemophagocytic Lymphohistiocytosis
Ericson, K. G., Fadeel, B., Nilsson-Ardnor, S., Söderhäll, C., Samuelsson, A., Janka, G., Schneider, M., Gürgey, A., Yalman, N., Révész, T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318796 · Cited by 249 · see citing works
Hypercytokinemia in Hemophagocytic Syndrome
Fujiwara, F., Hibi, S., & Imashuku, S. (1993) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199302000-00012 · Cited by 242 · see citing works
A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection
Matloubian, M., Suresh, M., Glass, A. A., Galvan, M., Chow, K., Whitmire, J. K., Walsh, C. M., Clark, W. R., & Ahmed, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2527-2536.1999 · Cited by 218 · see citing works
Hermans, I. F., Ritchie, D. S., Yang, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3095 · Cited by 216 · see citing works
Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., & Hamilton, J. A. (2001) · Arthritis Research & Therapy · doi:10.1186/ar318 · Cited by 186 · see citing works
Ou, R., Zhou, S., Huang, L., & Moskophidis, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8407-8423.2001 · Cited by 175 · see citing works
Akashi, K., Hayashi, S., Gondo, H., et al. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04905.x · Cited by 171 · see citing works
Kägi, D., & Hengartner, H. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80033-1 · Cited by 167 · see citing works
Characteristic Immune Abnormalities in Hemophagocytic Lymphohistiocytosis
Egeler, R. M., Shapiro, R., Loechelt, B. J., & Filipovich, A. H. (1996) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199611000-00002 · Cited by 165 · see citing works
Schneider, E. M., Lorenz, I., Müller-Rosenberger, M., Steinbach, G., Kron, M., & Janka-Schaub, G. E. (2002) · Blood · doi:10.1182/blood-2001-12-0260 · Cited by 158 · see citing works
Binder, D., van den Broek, M. F., Kägi, D., Bluethmann, H., Fehr, J., Hengartner, H., & Zinkernagel, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1903 · Cited by 138 · see citing works
Ohga, S., Matsuzaki, A., Nishizaki, M., et al. (1993) · PubMed · Cited by 127 · see citing works
Badovinac, V. P., Hamilton, S. E., & Harty, J. T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00079-7 · Cited by 116 · see citing works
Oversecretion of IL‐18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity
Takada, H., Ohga, S., Mizuno, Y., Suminoe, A., Matsuzaki, A., Ihara, K., Kinukawa, N., Ohshima, K., Kohno, K., Kurimoto, M., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01504.x · Cited by 114 · see citing works
Murayama, T., Yokode, M., Kataoka, H., Imabayashi, T., Yoshida, H., Sano, H., Nishikawa, S., Nishikawa, S., & Kita, T. (1999) · Circulation · doi:10.1161/01.cir.99.13.1740 · Cited by 95 · see citing works
Heise, M. T., Connick, M., & Virgin, H. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1037 · Cited by 88 · see citing works
Baldridge, J. R., & Buchmeier, M. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4252-4257.1992 · Cited by 85 · see citing works
A Unique Mechanism for Innate Cytokine Promotion of T Cell Responses to Viral Infections
Pien, G. C., Nguyen, K. B., Malmgaard, L., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5827 · Cited by 82 · see citing works
The role of cytotoxicity in lymphocyte homeostasis
Basile, G. D. S., & Fischer, A. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00257-0 · Cited by 79 · see citing works
Proteins of lymphocytic choriomeningitis virus: Antigenic topography of the viral glycoproteins
Parekh, B., & Buchmeier, M. J. (1986) · Virology · doi:10.1016/0042-6822(86)90020-6 · Cited by 79 · see citing works
Snoeck, H., Bockstaele, D. R. V., Nys, G., Lenjou, M., Lardon, F., Haenen, L., Rodrigus, I. R., Peetermans, M. E., & Berneman, Z. N. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.1177 · Cited by 66 · see citing works
General and specific immunosuppression caused by antiviral T‐cell responses
Zinkernagel, R. M., Planz, O., Ehl, S. R., et al. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01300.x · Cited by 53 · see citing works
Perforin and Fas in murine gammaherpesvirus-specific CD8+ T cell control and morbidity
Topham, D. J., Cardin, R. C., Christensen, J. P., et al. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-8-1971 · Cited by 44 · see citing works
LoPiccolo, D. M., Gold, M. C., Kavanagh, D. G., et al. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.301-308.2003 · Cited by 38 · see citing works
Enhanced Antibody and Cytokine Responses to Influenza Viral Antigens in Perforin-Deficient Mice
Sambhara, S. R., Switzer, I., Kurichh, A., Miranda, R., Urbanczyk, L., James, O., Underdown, B. J., Klein, M. H., & Burt, D. S. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1314 · Cited by 37 · see citing works
Baldridge, J. R., McGraw, T., Paoletti, A. D., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.755-758.1997 · Cited by 36 · see citing works
Anti-Interleukin-18 Therapy in Murine Models of Inflammatory Bowel Disease
Lochner, M., & Förster, I. (2002) · Pathobiology · doi:10.1159/000068149 · Cited by 35 · see citing works
Liu, B., Mori, I., Hossain, M. J., et al. (2003) · Microbial Pathogenesis · doi:10.1016/s0882-4010(02)00191-2 · Cited by 25 · see citing works
Lochner, M., Wagner, H., Classen, M., & Förster, I. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00505-1 · Cited by 23 · see citing works
Paolini, R., Serra, A., Molfetta, R., Piccoli, M., Frati, L., & Santoni, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10 · Cited by 22 · see citing works
Saito, T., Tsunematsu, Y., Saeki, M., Honna, T., Masaki, E., Kojima, Y., & Miyauchi, J. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199709)29:3 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943 · see citing works
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196 · see citing works
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Beura, L. K., Hamilton, S. E., Bi, K., Schenkel, J. M., Odumade, O. A., Casey, K. A., Thompson, E. A., Fraser, K. A., Rosato, P. C., Filali-Mouhim, A., et al. (2016) · Nature · doi:10.1038/nature17655 · Cited by 1,072 · see citing works
The Immunology of Macrophage Activation Syndrome
Crayne, C. B., Albeituni, S., Nichols, K. E., & Cron, R. Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00119 · Cited by 633 · see citing works
Perforin-mediated target-cell death and immune homeostasis
Voskoboinik, I., Smyth, M. J., & Trapani, J. A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1983 · Cited by 592 · see citing works
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911326 · Cited by 534 · see citing works
Self-citationRepeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
Behrens, E. M., Canna, S. W., Slade, K., Rao, S., Kreiger, P. A., Paessler, M., Kambayashi, T., & Koretzky, G. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43157 · Cited by 392 · see citing works
Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321 · see citing works
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Marsh, R. A., Allen, C. E., McClain, K. L., Weinstein, J. L., Kanter, J., Skiles, J., Lee, N. D., Khan, S. P., Lawrence, J., Mo, J. Q., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24188 · Cited by 310 · see citing works
Self-citationSevere imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290 · see citing works
Hemophagocytosis causes a consumptive anemia of inflammation
Zoller, E. E., Lykens, J. E., Terrell, C. E., Aliberti, J., Filipovich, A. H., Henson, P. M., & Jordan, M. B. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102538 · Cited by 228 · see citing works
Self-citationSalim, T., Sershen, C. L., & May, E. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153289 · Cited by 210 · see citing works
Johnson, T. S., Terrell, C. E., Millen, S. H., Katz, J. D., Hildeman, D. A., & Jordan, M. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302282 · Cited by 203 · see citing works
Self-citationPerforin is a critical physiologic regulator of T-cell activation
Lykens, J. E., Terrell, C. E., Zoller, E. E., Risma, K., & Jordan, M. B. (2011) · Blood · doi:10.1182/blood-2010-12-324533 · Cited by 150 · see citing works
Self-citationThe role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease
Morales-Mantilla, D. E., & King, K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0139-3 · Cited by 99 · see citing works
Avau, A., Mitera, T., Put, S., Put, K., Brisse, E., Filtjens, J., Uyttenhove, C., Van Snick, J., Liston, A., Leclercq, G., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38359 · Cited by 90 · see citing works
Wang, A., Pope, S. D., Weinstein, J. S., Yu, S., Zhang, C., Booth, C. J., & Medzhitov, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820704116 · Cited by 67 · see citing works
Bacterial stimulation of toll-like receptor 4 drives macrophages to hemophagocytose
McDonald, E. M., Pilonieta, M. C., Nick, H. J., & Detweiler, C. S. (2016) · Infection and Immunity · doi:10.1128/iai.01149-15 · Cited by 18 · see citing works
Single MHC‐I Expression Promotes Virus‐Induced Liver Immunopathology
Xu, H. C., Huang, J., Pandyra, A. A., Pandey, P., Wang, R., Zhang, Z., Zhuang, Y., Gertzen, C. G. W., Münk, C., Herebian, D., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1913 · Cited by 9 · see citing works
- Authors
- Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-08-01
- Volume
- 104
- Issue
- 3
- Pages
- 735-743
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1983067071
- Cited by
- 712
- References
- 49
- Citations by year
- 2026: 18 · 2025: 35 · 2024: 48 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 51 · 2019: 46 · 2018: 22 · 2017: 45 · 2016: 43 · 2015: 37 · 2014: 28 · 2013: 23 · 2012: 27
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1k08ai050802-01a1)
- National Institute of Allergy and Infectious Diseases (AI-18785, AI 17134, AI-52225, R01AI052225, AI-50802)
- Topics
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- hemophagocytic lymphohistiocytosis, perforin-deficient mice, CD8+ T cells, interferon-gamma, lymphocytic choriomeningitis virus, hemophagocytosis, natural killer cells, antigen presentation, cytokine neutralization, lymphocyte cytotoxicity, hypertriglyceridemia, hypofibrinogenemia, pancytopenia, splenomegaly, animal models
- MeSH terms
- Animals, beta 2-Microglobulin, Disease Models, Animal, Humans, Interferon-gamma, Killer Cells, Natural, Mice, Inbred C57BL, Histiocytosis, Non-Langerhans-Cell, Immunophenotyping, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review